Literature DB >> 12734331

Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity.

Neely E Kilgore1, Jenny D Carter, Ulrike Lorenz, Brian D Evavold.   

Abstract

The mechanism by which antagonist peptides inhibit T cell responses is unknown. Mice deficient in Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1) have revealed its importance in the negative regulation of lymphocyte signaling. We investigated a possible role for SHP-1 in T cell antagonism and demonstrate, for the first time, a substantial increase in SHP-1 activity during antagonism of CD4(+) T cells. Furthermore, the removal of functional SHP-1 prevents antagonism in these cells. Our data demonstrate that T cell antagonism occurs via a negative intracellular signal that is mediated by SHP-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734331     DOI: 10.4049/jimmunol.170.10.4891

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

3.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

4.  Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection.

Authors:  Ryan J Martinez; Anna B Morris; Dennis K Neeld; Brian D Evavold
Journal:  Eur J Immunol       Date:  2016-09       Impact factor: 5.532

Review 5.  Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.

Authors:  Joseph J Sabatino; Kristen M Rosenthal; Brian D Evavold
Journal:  J Neuroimmune Pharmacol       Date:  2009-11-11       Impact factor: 4.147

6.  Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope.

Authors:  Philip J Norris; Jennifer D Stone; Nadezhda Anikeeva; John W Heitman; Ingrid C Wilson; Dale F Hirschkorn; Margaret J Clark; Howell F Moffett; Thomas O Cameron; Yuri Sykulev; Lawrence J Stern; Bruce D Walker
Journal:  Mol Immunol       Date:  2005-10-07       Impact factor: 4.407

Review 7.  T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

8.  Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Authors:  Jennifer D Stone; David H Aggen; Adam S Chervin; Samanthi Narayanan; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

Review 9.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development.

Authors:  Philippe Pouliot; Sébastien Bergeron; André Marette; Martin Olivier
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.